Article

Molecular diagnosis of familial adenomatous polyposis.

Johns Hopkins University, Baltimore, Maryland, United States
New England Journal of Medicine (Impact Factor: 54.42). 01/1994; 329(27):1982-7. DOI: 10.1056/NEJM199312303292702
Source: PubMed

ABSTRACT Familial adenomatous polyposis is an inherited disease characterized by multiple colorectal tumors. The diagnosis has classically been based on the detection of multiple colorectal adenomas. The recent identification of germline mutations of the APC gene in patients with familial adenomatous polyposis makes presymptomatic molecular diagnosis possible, but the widespread distribution of the many mutations within this very large gene have heretofore made the search for such mutations impractical. We describe a novel approach that allows molecular genetic diagnosis in the majority of patients with the disease.
We screened 62 unrelated patients from the Johns Hopkins Familial Adenomatous Polyposis Registry for germline APC mutations. Primary screening was accomplished by analysis of protein synthesized in vitro from surrogate APC genes. In addition, the relative amount of transcript from each APC allele was determined with an allele-specific--expression assay.
The protein assay revealed truncated protein in 51 of the 62 patients (82 percent). In 3 of the 11 remaining patients, the allele-specific--expression assay revealed significantly reduced expression of one allele of the APC gene. The use of these two assays in combination successfully identified germline APC mutations in 87 percent of the 62 patients.
The protein and allele-specific--expression assays provide a practical and sensitive method for molecular diagnosis of familial adenomatous polyposis. This approach will facilitate care, allowing routine testing of subjects at risk and genetic confirmation of spontaneous mutations.

0 Followers
 · 
71 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Colorectal cancer is an important problem in the United States, with over 130,000 new cases and 55,000 deaths each year. There is now strong evidence that screening for colorectal cancer with fecal occult blood testing can decrease mortality, and additional evidence that removing benign adenomas can decrease cancer incidence. Evidence-based screening guidelines depend on colorectal cancer risk. Individuals at higher risk because of a personal or family history deserve more intensive screening than asymptomatic individuals over age 50.
    Medical Clinics of North America 11/1999; 83(6):1403-1422. DOI:10.1016/S0025-7125(05)70172-3 · 2.80 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Sklifasowski rapporterade 1881 det första säkra fallet av familjär adenomatös polypos (fap). Omvandlingen av en polyp till karci-nom beskrevs 1890 av Hanford. Den autoso-mala dominanta arvsgången beskrevs 1927 av Cockayne [1]. Gardner beskrev en släkt med polypos, multipla osteom och epidermoidcystor, vilket han ansåg vara en särskild genetisk sjukdom [2]. Sjukdomen kallas Gardners syndrom. Senare har desmoidtumörer och tandmiss-bildningar fogats till sjukdomsbilden. Gard-ners syndrom anses emellertid vara en variant av samma genetiska sjukdom där olika mani-festationer av fap uppträder utanför tarmen. Alm publicerade 1975 de första resultaten av behandling av familjär polypos på basis av det första nationella registret [3, 4]. Herrera och medarbetare upptäckte 1986 en deletion i den långa armen av kromo-som 5 hos en patient med Gardners syn-drom [5]. Följande år lokaliserades fap-lokuset med kopplingsanalys till regionen 5q21-22 [6]. apc-genen (adenomatous po-lyposis coli) lokaliserades 1991 och dess sekvens klargjordes [7, 8].
  • Genetics in Medicine 11/1999; 2(6):362-366. · 6.44 Impact Factor